Skip to main content

Table 12 The mean lifetime attributed cancer mortality risks due to whole lung low dose radiotherapy (with a prescribed dose equal to 1 Gy) in VMAT technique for adult male and female patients at different ages

From: Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia

  Age at exposure time (years)
20 30 40 50 60 70 80
Male
Stomach 0.095 0.072 0.068 0.059 0.050 0.036 0.018
Liver 0.131 0.091 0.091 0.080 0.068 0.046 0.023
Lung 1.661 1.177 1.177 1.144 1.023 0.781 0.462
Other 0.208 0.146 0.136 0.119 0.090 0.056 0.026
All solids 2.094 1.486 1.472 1.402 1.231 0.918 0.529
Female
Stomach 0.131 0.095 0.090 0.086 0.072 0.059 0.036
Liver 0.068 0.051 0.046 0.046 0.040 0.029 0.017
Lung 3.355 2.343 2.332 2.244 2.013 1.540 0.891
Breast 0.596 0.360 0.207 0.112 0.053 0.030 0.012
Other 0.228 0.160 0.150 0.133 0.107 0.073 0.037
All solids 4.378 3.008 2.824 2.621 2.285 1.729 0.993
  1. Risk values are presented as incidence probability per 100 individuals